EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 356 filers reported holding EMERGENT BIOSOLUTIONS INC in Q3 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,725,306 | -75.1% | 801,603 | -46.2% | 0.00% | -66.7% |
Q2 2023 | $10,949,156 | -41.6% | 1,489,585 | -17.7% | 0.00% | -50.0% |
Q1 2023 | $18,760,883 | +86272.1% | 1,810,929 | -1.5% | 0.01% | 0.0% |
Q4 2022 | $21,721 | -99.9% | 1,839,161 | -4.3% | 0.01% | -60.0% |
Q3 2022 | $40,348,000 | -33.2% | 1,922,230 | -1.3% | 0.02% | -31.8% |
Q2 2022 | $60,443,000 | +7.6% | 1,947,332 | +42.3% | 0.02% | +29.4% |
Q1 2022 | $56,199,000 | +26.0% | 1,368,661 | +33.4% | 0.02% | +30.8% |
Q4 2021 | $44,590,000 | -9.7% | 1,025,697 | +4.0% | 0.01% | -18.8% |
Q3 2021 | $49,401,000 | -19.6% | 986,560 | +1.1% | 0.02% | -15.8% |
Q2 2021 | $61,470,000 | -36.9% | 975,838 | -7.0% | 0.02% | -40.6% |
Q1 2021 | $97,461,000 | +4.9% | 1,049,045 | +1.2% | 0.03% | -5.9% |
Q4 2020 | $92,906,000 | -23.2% | 1,036,814 | -11.5% | 0.03% | -33.3% |
Q3 2020 | $121,036,000 | +22.6% | 1,171,334 | -6.2% | 0.05% | +18.6% |
Q2 2020 | $98,738,000 | +34.8% | 1,248,712 | -1.3% | 0.04% | +13.2% |
Q1 2020 | $73,231,000 | +3.5% | 1,265,790 | -3.5% | 0.04% | +46.2% |
Q4 2019 | $70,756,000 | -9.7% | 1,311,500 | -12.5% | 0.03% | -13.3% |
Q3 2019 | $78,352,000 | -1.0% | 1,498,749 | -8.5% | 0.03% | -3.2% |
Q2 2019 | $79,156,000 | -1.6% | 1,638,499 | +2.9% | 0.03% | -3.1% |
Q1 2019 | $80,467,000 | -19.7% | 1,592,790 | -5.7% | 0.03% | -28.9% |
Q4 2018 | $100,167,000 | -12.9% | 1,689,740 | -3.3% | 0.04% | +2.3% |
Q3 2018 | $115,059,000 | +11.9% | 1,747,821 | -14.2% | 0.04% | +7.3% |
Q2 2018 | $102,813,000 | -11.5% | 2,036,284 | -7.7% | 0.04% | -14.6% |
Q1 2018 | $116,123,000 | +11.2% | 2,205,564 | -1.8% | 0.05% | +11.6% |
Q4 2017 | $104,400,000 | +16.0% | 2,246,550 | +1.0% | 0.04% | +10.3% |
Q3 2017 | $89,968,000 | +20.3% | 2,224,198 | +0.8% | 0.04% | +11.4% |
Q2 2017 | $74,795,000 | +25.4% | 2,205,712 | +7.4% | 0.04% | +20.7% |
Q1 2017 | $59,639,000 | -10.3% | 2,053,683 | +1.4% | 0.03% | -12.1% |
Q4 2016 | $66,512,000 | +3.1% | 2,025,318 | -1.0% | 0.03% | -5.7% |
Q3 2016 | $64,514,000 | +6.7% | 2,046,250 | -4.8% | 0.04% | 0.0% |
Q2 2016 | $60,453,000 | -19.3% | 2,149,815 | +4.3% | 0.04% | -22.2% |
Q1 2016 | $74,943,000 | -2.0% | 2,061,744 | +7.9% | 0.04% | -6.2% |
Q4 2015 | $76,485,000 | +49.2% | 1,911,645 | +6.3% | 0.05% | +41.2% |
Q3 2015 | $51,260,000 | -9.1% | 1,799,193 | +5.2% | 0.03% | -2.9% |
Q2 2015 | $56,364,000 | +22.8% | 1,710,650 | +7.2% | 0.04% | +20.7% |
Q1 2015 | $45,897,000 | +12.3% | 1,595,862 | +6.3% | 0.03% | +7.4% |
Q4 2014 | $40,877,000 | +29.3% | 1,501,159 | +1.2% | 0.03% | +22.7% |
Q3 2014 | $31,613,000 | -4.6% | 1,483,417 | +0.5% | 0.02% | -4.3% |
Q2 2014 | $33,153,000 | +2.6% | 1,476,073 | +15.5% | 0.02% | -4.2% |
Q1 2014 | $32,306,000 | +18.6% | 1,278,440 | +7.9% | 0.02% | +14.3% |
Q4 2013 | $27,230,000 | +31.8% | 1,184,393 | +9.2% | 0.02% | +16.7% |
Q3 2013 | $20,660,000 | +36.3% | 1,084,546 | +3.2% | 0.02% | +28.6% |
Q2 2013 | $15,156,000 | – | 1,051,056 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Broadfin Capital, LLC | 2,080,519 | $44,336,000 | 4.65% |
GREAT POINT PARTNERS LLC | 290,000 | $6,180,000 | 2.65% |
FIDUCIARY MANAGEMENT ASSOCIATES LLC | 651,884 | $13,892,000 | 0.99% |
Matarin Capital Management, LLC | 85,003 | $1,811,414,000 | 0.83% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 407,000 | $8,673,000 | 0.39% |
ICON ADVISERS INC/CO | 258,478 | $5,508,000 | 0.32% |
RMB Capital Management, LLC | 178,204 | $3,798,000 | 0.23% |
NEW AMSTERDAM PARTNERS LLC/NY | 159,470 | $3,398,000 | 0.23% |
GLOBEFLEX CAPITAL L P | 94,016 | $2,003,000 | 0.23% |
Convergence Investment Partners, LLC | 58,672 | $1,250,000 | 0.17% |